Durable Remissions with Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in CAR-Naive and CAR-Exposed Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
Year: 2017
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Shannon L. Maude, George Hucks, Colleen Callahan, Diane Baniewicz, Christina Fasano, Christine Barker, Susan R. Rheingold, Richard Aplenc, Amanda M. DiNofia, Amanda Li, David T. Teachey, David M. Barrett, Jennifer L. Brogdon, Regina M. Young, John Scholler, Katherine T. Marcucci, Bruce L. Levine, Noelle V. Frey, David L. Porter, Simon F. Lacey, J. Joseph Melenhorst, Carl H. June, Stephan A. Grupp
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2909969433